Literature DB >> 17245624

The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells.

Huda H Al-Khalaf1, Boleslaw Lach, Ayman Allam, Ahmed AlKhani, Salman A Alrokayan, Abdelilah Aboussekhra.   

Abstract

Although meningiomas represent the most common class of tumors of the central nervous system, the molecular events underlying their genesis and development are still not well defined. In the present study we have used the immuno-blotting technique to study the expression level of the tumor suppressor proteins p53, p21 and PTEN in primary meningioma cells. We have also studied the induction of p21 and p53 in response to both UV light and gamma-rays. We present evidence that the p53/p21-dependent gamma-ray signaling pathway is defective in 5 out of 8 (62%) of these cells. Furthermore, we have shown that the tumor suppressor p21, p53 and PTEN proteins are differently expressed in these cells, with up to 40-folds difference between the lowest and the highest levels of each protein. These results suggest that the tumor suppressors p53/p21 signaling pathway and PTEN play important roles in the development of benign meningiomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245624     DOI: 10.1007/s11060-006-9301-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

1.  The initiation of UV-induced G(1) arrest in human cells is independent of the p53/p21/pRb pathway but can be attenuated through expression of the HPV E7 oncoprotein.

Authors:  Martin Loignon; Elliot A Drobetsky
Journal:  Carcinogenesis       Date:  2002-01       Impact factor: 4.944

Review 2.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 3.  p53: 25 years after its discovery.

Authors:  Lorne J Hofseth; S Perwez Hussain; Curtis C Harris
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

Review 4.  Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.

Authors:  Igor B Roninson
Journal:  Cancer Lett       Date:  2002-05-08       Impact factor: 8.679

5.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

Review 6.  Regulation of p53 downstream genes.

Authors:  W S el-Deiry
Journal:  Semin Cancer Biol       Date:  1998       Impact factor: 15.707

7.  Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.

Authors:  K M Meyer; S M Hess; T D Tlsty; S A Leadon
Journal:  Oncogene       Date:  1999-10-14       Impact factor: 9.867

Review 8.  ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses.

Authors:  Jun Yang; Yingnian Yu; Hope E Hamrick; Penelope J Duerksen-Hughes
Journal:  Carcinogenesis       Date:  2003-08-14       Impact factor: 4.944

9.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation.

Authors:  T Haapajärvi; L Kivinen; K Pitkänen; M Laiho
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

View more
  6 in total

Review 1.  Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature.

Authors:  Kengo Suzuki; Hiroyuki Momota; Akiko Tonooka; Hiroko Noguchi; Kouhei Yamamoto; Masahiko Wanibuchi; Yoshihiro Minamida; Tadashi Hasegawa; Kiyohiro Houkin
Journal:  J Neurooncol       Date:  2010-01-10       Impact factor: 4.130

2.  Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Tomislav Vladušić; Davor Tomas; Monika Logara; Josip Skoko; Reno Hrašćan
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

3.  A role for the p53 pathway in the pathology of meningiomas with NF2 loss.

Authors:  ZeNan Chang; Chin-Lin Guo; Iris Ahronowitz; Anat O Stemmer-Rachamimov; Mia MacCollin; Fabio P Nunes
Journal:  J Neurooncol       Date:  2008-11-01       Impact factor: 4.130

4.  PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage.

Authors:  B H Huang; J L Zhuo; C H W Leung; G D Lu; J J Liu; C T Yap; S C Hooi
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

5.  Increased Risk of the APOB rs11279109 Polymorphism for CHD among the Kuwaiti Population.

Authors:  Suzanne A Al-Bustan; Fatma G Ismael; Ahmad Al-Serri; Ibrahim Al-Rashdan
Journal:  Dis Markers       Date:  2017-12-06       Impact factor: 3.434

6.  Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance.

Authors:  Anja Bukovac; Anja Kafka; Reno Hrašćan; Tomislav Vladušić; Nives Pećina-Šlaus
Journal:  Mol Clin Oncol       Date:  2019-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.